Table 2

Overall survival by Cox proportional hazards regression at survival periods 0–1, 0–2, 0–5 and 0–10 years post-surgery

Period of follow-upAdjusted I*Adjusted IIFully adjusted
Season of surgeryHR (95% CI)p ValueHR (95% CI)p ValueHR (95% CI)p Value
0–1 years after surgery
 Winter1 (reference)0.0531 (reference)0.0671 (reference)0.052
 Spring1.07 (0.95 to 1.20)1.06 (0.95 to 1.19)1.07 (0.96 to 1.20)
 Summer1.09 (0.97 to 1.22)1.08 (0.96 to 1.21)1.12 (1.00 to 1.25)
 Autumn0.95 (0.84 to 1.06)0.94 (0.84 to 1.06)0.97 (0.86 to 1.09)
0–2 years after surgery
 Winter1 (reference)0.191 (reference)0.171 (reference)0.43
 Spring0.99 (0.92 to 1.06)0.98 (0.92 to 1.06)1.00 (0.93 to 1.07)
 Summer0.99 (0.92 to 1.06)0.99 (0.92 to 1.06)1.01 (0.94 to 1.08)
 Autumn0.93 (0.87 to 1.00)0.93 (0.86 to 1.00)0.96 (0.89 to 1.03)
0–5 years after surgery
 Winter1 (reference)0.601 (reference)0.481 (reference)0.96
 Spring0.98 (0.94 to 1.03)0.98 (0.94 to 1.03)1.00 (0.95 to 1.04)
 Summer0.98 (0.94 to 1.02)0.97 (0.93 to 1.02)1.00 (0.95 to 1.04)
 Autumn0.97 (0.93 to 1.01)0.97 (0.93 to 1.01)0.99 (0.95 to 1.03)
0–10 years after surgery
 Winter1 (reference)0.901 (reference)0.811 (reference)0.92
 Spring1.00 (0.96 to 1.03)1.00 (0.96 to 1.03)1.01 (0.98 to 1.05)
 Summer1.00 (0.96 to 1.03)0.99 (0.96 to 1.03)1.01 (0.98 to 1.05)
 Autumn0.99 (0.95 to 1.02)0.98 (0.95 to 1.02)1.00 (0.97 to 1.04)
  • Estimates of season of surgery are shown among 79 658 Danish women operated for breast cancer between 1 June 1978 and 31 May 2010.

  • * Model stratified for treatment programme.

  • Model stratified for treatment programme and age at surgery.

  • Model stratified for treatment programme, age at surgery, hormone receptor status and nodal status and including the effects of tumour size and histological group.